Position in ESPR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$98,253
+$35,729 QoQ
Shares Held
35,859
+53.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Derivatives in ESPR
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$17,236
PutShares
12,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LMR Partners LLP holds $45,048,985 across 4 Drug Manufacturers - Specialty & Generic names. ESPR ranks #4 (0.2% of the industry book) .
All Filings in ESPR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $98,253 | 35,859 | Shares | Other | 2026-05-15 | |
| 2024-03-31 | $62,524 | 23,330 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $17,236 | 12,400 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $17,236 | 12,400 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,716 | 12,400 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||